ENO2 and neoplasm: Among these markers, CEA, CA199, and CYFRA21‐1 levels significantly increased with the increase in tumor size (p < 0.05), whereas AFP, CA724, and NSE showed no significant differential expression levels in patients with different tumor sizes (p >0.05).